PILONI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 2.135
AS - Asia 1.584
EU - Europa 1.192
SA - Sud America 286
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 82
OC - Oceania 4
Totale 5.382
Nazione #
US - Stati Uniti d'America 2.056
CN - Cina 451
SG - Singapore 406
IT - Italia 246
VN - Vietnam 245
BR - Brasile 225
RU - Federazione Russa 211
HK - Hong Kong 203
DE - Germania 155
IE - Irlanda 149
FI - Finlandia 114
FR - Francia 94
BD - Bangladesh 91
GB - Regno Unito 67
IN - India 59
ZA - Sudafrica 53
CA - Canada 38
MX - Messico 23
AR - Argentina 22
NL - Olanda 22
PL - Polonia 21
ES - Italia 20
IQ - Iraq 19
AT - Austria 17
SE - Svezia 15
UA - Ucraina 15
CO - Colombia 14
ID - Indonesia 13
JP - Giappone 13
BE - Belgio 12
PH - Filippine 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
PK - Pakistan 10
TR - Turchia 9
CL - Cile 7
SA - Arabia Saudita 7
IL - Israele 6
TN - Tunisia 6
EG - Egitto 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
JM - Giamaica 4
VE - Venezuela 4
BY - Bielorussia 3
DZ - Algeria 3
IR - Iran 3
JO - Giordania 3
KH - Cambogia 3
KZ - Kazakistan 3
PA - Panama 3
RO - Romania 3
TH - Thailandia 3
UZ - Uzbekistan 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
HN - Honduras 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
MT - Malta 2
MY - Malesia 2
PE - Perù 2
TW - Taiwan 2
DK - Danimarca 1
DM - Dominica 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 5.284
Città #
San Jose 295
Singapore 228
Ashburn 214
Dallas 207
Hong Kong 196
Dublin 149
Beijing 137
Chandler 128
Council Bluffs 116
Ho Chi Minh City 86
Munich 73
New York 68
Los Angeles 67
Hanoi 60
Milan 59
Lauterbourg 57
Helsinki 55
Johannesburg 51
Turku 51
Boardman 48
Moscow 38
Pavia 38
Redondo Beach 33
Santa Clara 27
Shanghai 26
Nanjing 22
Nuremberg 22
Columbus 21
Orem 20
Princeton 20
Warsaw 20
Lawrence 19
Phoenix 19
Atlanta 18
Jacksonville 17
Chicago 16
Medford 16
Shenyang 16
São Paulo 16
Denver 15
London 15
Montreal 15
Brooklyn 14
Buffalo 14
Changsha 14
Frankfurt am Main 14
Ann Arbor 13
Chennai 13
Nanchang 13
Rome 13
Falkenstein 12
Jiaxing 12
Mexico City 12
Montesilvano Marina 12
Poplar 12
Tokyo 12
Da Nang 11
Haiphong 11
Stockholm 11
Wilmington 11
Brussels 10
Florence 10
Paris 10
Seattle 9
The Dalles 9
Vienna 9
Amsterdam 8
Houston 8
Manchester 8
Rio de Janeiro 8
Toronto 8
Baghdad 7
Belo Horizonte 7
Boston 7
Brno 7
Hebei 7
Cagliari 6
Guangzhou 6
Hải Dương 6
Lyon 6
Madrid 6
Tianjin 6
Washington 6
Can Tho 5
Düsseldorf 5
Karachi 5
Naples 5
Porto Alegre 5
Pune 5
Riyadh 5
Augusta 4
Biên Hòa 4
Bologna 4
Brescia 4
Bridgetown 4
Buenos Aires 4
Curitiba 4
Erbil 4
Fairfield 4
Ha Long 4
Totale 3.287
Nome #
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 189
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 178
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 161
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 160
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 153
(1)H NMR To Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification. 146
Assessment and management of pulmonary alveolar proteinosis in a reference center. 140
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 138
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 135
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 134
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 133
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 132
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 125
Asthma-like symptoms: Is it always a pulmonary issue? 114
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 112
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 108
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 105
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 102
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 101
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 99
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 99
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 98
Machine Learning-based Voice Assessment for the Detection of Positive and Recovered COVID-19 Patients 97
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 96
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 94
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 92
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients 91
Risk stratification in patients with residual pulmonary hypertension after pulmonary endarterectomy 88
Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension? 87
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 86
Phenotyping sarcoidosis: a single institution retrospective analysis 83
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 82
Phenotypes and Serum Biomarkers in Sarcoidosis 81
High prevalence of acute stress disorder and persisting symptoms in ICU survivors after COVID-19 81
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 80
COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining 78
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 78
A mini-whole lung lavage to treat autoimmune pulmonary alveolar proteinosis (PAP) 78
Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study 76
Predictive markers associated to fibrotic evolution in hypersensitivity pneumonitis: a single institution's analysis 72
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review 72
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 71
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 70
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 68
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 67
Partition analysis of data of two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience 67
Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD 66
Inhaled corticosteroids and risk of osteoporosis in late-middle age subjects: a multicenter European cohort study 62
Right single lung transplantation or double lung transplantation compared with left single lung transplantation in chronic obstructive pulmonary disease 58
Study of acceptance/rejection mechanisms in lung allograft recipients and development of a new therapeutic approach based on nanotechnology 58
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 56
Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study 45
BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance. 44
Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation 42
Lung tumors, COPD and immune response: is epigenetics the bottom line? 39
Lymph-node mapping in lung cancer staging: accuracy and limits of the current approaches 34
Prolonged-release oxycodone-naloxone for pain management in advanced EGFR wild-type lung cancer patients 29
Quantitative analysis of airway obstruction in lymphangioleiomyomatosis 27
Exploring adjuvant epidermal growth factor receptor inhibition in non-small cell lung cancer 25
Totale 5.382
Categoria #
all - tutte 22.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 1 3 0 1 1 0 5 7 4 13 48
2022/2023387 40 36 7 29 25 32 0 15 175 2 19 7
2023/2024315 44 53 14 15 47 57 16 20 5 15 8 21
2024/20251.225 31 31 45 48 30 128 73 74 296 69 134 266
2025/20262.886 220 145 307 344 362 88 499 127 309 197 174 114
2026/2027225 128 97 0 0 0 0 0 0 0 0 0 0
Totale 5.382